Shanghai Microport Endovascular Medtec(Group) Co.,Ltd.’s Net Profit Rose 12.3% in 2022

Shanghai Microport Endovascular Medtec(Group) Co.,Ltd. (上海微创心脉医疗科技(集团)股份有限公司) (688016.SH) reported a net profit of 352.1 million yuan in 2022, up 12.3% year-on-year.

Meanwhile, the company posted 896.5 million yuan in revenue, up 30.9% year-on-year.

At the end of the reporting period, it had 2 billion yuan in total assets and 252.5 million yuan in total liabilities, with a liability-to-asset ratio of 12.7%.